Author

Ana Belén Griso-Acevedo

Hospital La Paz Institute for Health ResearchORCID 0009-0006-0745-4605Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Ana Sastre-PeronaiD· 1 shared Beatriz CasteloiD· 1 shared Francisco NavasiD· 1 shared Javier GonzaleziD· 1 shared José Luis Cebrián-CarreteroiD· 1 shared María José Morán SotoiD· 1 shared Natalia L. CalvoiD· 1 shared Rafael A. García‐MuñoziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Sastre-PeronaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 23, 2026

Overcoming Cisplatin Resistance in 3D Oral Squamous Cell Carcinoma Models via Nanoparticle-Mediated Pt(IV) Drug Delivery.

Ana Belén Griso-Acevedo, Francisco Navas, Natalia L. Calvo…·Ana Sastre-Perona

This study evaluates Pt(IV)-based prodrug delivery via mesoporous silica nanoparticles in 3D oral squamous cell carcinoma models, showing improved cytotoxicity and apoptotic effects compared to cisplatin.

DOI 10.64898/2026.02.22.707247

humanbulk RNA-seq

𝕏 PostBluesky